Autologous stem cell transplant for severe, progressive juvenile systemic sclerosis.

Definition, diagnosis, treatment for scleroderma primary heart involvement.

A practical clinical approach to the diagnosis and management of morphea (localized scleroderma).

Automatic assessment of lung involvement in systemic sclerosis using deep learning.

Prevalence of comorbidities and medication use in progressive systemic sclerosis in northeast Mexico.

Implications of Dermatologic Disorders in Facial Cosmetic Surgery: A Systematic Review.

Circumscribed Morphea Successfully Treated With Excimer Laser: Analysis of Histopathological Changes.

Strabismus as the Initial Manifestation of En Coup De Sabre in Adult Patients.

The immune landscape of systemic sclerosis: from pathogenic mechanisms to precision therapeutic breakthroughs.

Risk score for early mortality to stratify for intensive SSc therapy in the EUSTAR network: the RESIST score.

Performance of Circulating Inflammatory Biomarkers and Krebs von den Lungen 6 for Predicting Progressive Pulmonary Fibrosis in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease.

Nailfold capillaroscopy improves cardiovascular risk stratification in SSc: an adjustment of the SCORE2 algorithm.

Fibrosis-memory is mediated by IL-3-producing T cells and drives progression of fibrosis.

Chronic graft versus host disease in upper limb: Calling upper limb rehabilitation specialists for improving outcomes in patients.

Optical coherence tomography angiography: a window on systemic sclerosis microangiopathy.

Real-World Adherence to Systemic Sclerosis Quality Indicators: A Single-Center Quality of Care Study.

Scleroderma sine-Raynaud in children: the Fibrotic Subtype.

Increased incidence of sudden cardiac death in systemic sclerosis: data from a nationwide cohort study.

Trends and outcomes of lung transplant listings for connective tissue disease-associated interstitial lung disease (CTD-ILD): A 20-Year analysis from the organ procurement and transplantation network database.

Exploring Disease-Specific Risk Factors for Vertebral Fractures in Systemic Sclerosis: Insights from the ScleroRER Study Group.

Nailfold capillaroscopy and organ involvement in systemic sclerosis: a systematic review.

Resting Oxygen Consumption Estimates in Scleroderma Can Lead to Underestimation of Cardiac Output.

Analysis of fungal community structure and co-occurrence networks across vegetation types in volcanic lava habitats.

Human MAGI1 expression in endothelial cells protects from the development of localized and systemic scleroderma in mice.

Objective gastrointestinal involvement in patients with systemic sclerosis: Prevalence and clinico-immunological phenotypes in the REMSCLE registry.

Dermatoscopy limitation and the critical role of capillaroscopy in the evaluation of systemic sclerosis and Raynaud's phenomenon among African American Veterans.

Prevention and management of gastrointestinal side effects in patients with systemic sclerosis-interstitial lung disease receiving anti-fibrotic therapy: a modified Delphi consensus study.

Intravenous immunoglobulin for the treatment of morphea in pediatric patients: A case series.

Community-based management of gastrointestinal symptoms at end-of-life in scleroderma using subcutaneous medication: a case report.

The Th17/Treg axis: a key to understanding and treating autoimmune disorders.

A novel microneedle-based delivery of NRF2-overexpressing exosomes for scleroderma therapy.

Nintedanib Attenuates Profibrotic Gene Expression in a 3D Organotypic Culture Model of Systemic Sclerosis Skin Fibrosis.

Longitudinal Assessment of the Juvenile Systemic Sclerosis Severity Score: Application in the National Registry for Childhood Onset Scleroderma.

A retrospective analysis of clinical characteristics of systemic sclerosis-associated interstitial lung disease.

Case of generalized morphea complicated with systemic sclerosis.

Exploring the anti-fibrotic effects of safflower in systemic sclerosis based on metabolomics and gut microbiota analyses.

Identification of key macrophage-related genes in systemic sclerosis-associated interstitial lung disease based on single-cell and bulk transcriptomic data.

The clinical phenotype of anti-Th/To+ patients in systemic sclerosis: a case-control study within the European Scleroderma Trials and Research cohort.

Not all small bowel pneumatosis is ischaemia: a case-based systematic review of non-ischaemic causes.

Recent advances in the heart and soul of primary cardiac involvement and cardiovascular disease in systemic sclerosis.

Ill by mouth? Patients' experiences of the oral and dental manifestations of scleroderma.

[Shulman syndrome: An atypical presentation of a rare disease].

Injectable platelet-rich fibrin as a valid therapeutic option for inactive linear morphea (en coup de saber): report of cases.

Generalized Morphea Successfully Treated With Tripterygium Glycosides and Hydroxychloroquine: A Case Report and a Systematic Review.

2025 expert consensus on the use of parenteral prostanoids in incident and prevalent PAH patients: The Italian perspective.

Evaluation of non-invasive techniques for the diagnosis of pulmonary complications in systemic sclerosis and scleroderma-like overlap syndromes: role of lung ultrasound.

The Incidence of Painful Neuroma After Digital Amputation Due to Trauma Versus Chronic Ischemia.

Outcomes Following Surgical Management of Advanced Oral Cavity Cancers in Patients with Scleroderma: A Case Series.

Reciprocal regulation of fibroblast-macrophage equilibrium governs skin integrity.

Scleroderma clinical trials consortium classification criteria for systemic sclerosis heart involvement.

Successful tocilizumab-based combination therapy for a case of rapidly progressive adult deep morphea with multiple antiphospholipid antibodies: a case report and literature review.

A university career in basic and applied avian immunology: important contributions of chicken models for autoimmune diseases.

Computed tomography of interstitial lung disease in systemic sclerosis: dataset and deep learning model for pulmonary lesion segmentation.

Temporomandibular joint disorders in patients with systemic sclerosis: a cross-sectional study.

Points to consider for reporting digital ulcers in systemic sclerosis interventional studies: An initiative from the world Scleroderma Foundation digital ulcer ad hoc committee.

Replay: Comparative Study of Adipose-Derived Stem Cells from Localized Scleroderma Patients and Healthy Donors in Treating Skin Fibrosis.

Extended temporomandibular joint prosthetic reconstruction of total condylysis in the setting of severe scleroderma: a case report.

Shared governance of international myositis networks.

Long-term follow-up of linear scleroderma en coup de sabre in children with central nervous system involvement.

A randomised open label pilot trial comparing mycophenolate mofetil with no immunosuppression in limited cutaneous systemic sclerosis (MINIMISE-Pilot).

Pericardial Decompression Syndrome After Large-Volume Pericardiocentesis in Systemic Sclerosis.

Integrating B Cell Differentiation Model With Real-World Data Informs Determinants for Antibody-Secreting Cell Depletions in Systemic Sclerosis.

Hyaluronic acid fillers in systemic sclerosis and localized scleroderma: A systematic review.

Evaluating context effects on PHQ-8 somatic item scores among people with a chronic medical condition: a scleroderma patient-centred intervention network randomised experiment.

Reduced retinal microvascular density in patients with mixed connective tissue disease: an exploratory pilot study on the interplay between aging, renal function, and complement system.

Case Report: Unusual persistent elevation of troponin I-systemic sclerosis masked by acute myocardial infarction.

Carbon dioxide vs. warm-water hand baths in systemic sclerosis with secondary Raynaud's syndrome - A capillaroscopy centered randomized controlled trial.

Drug development in systemic sclerosis: novel therapeutics to watch.

Prevalence and clinical relevance of systematically tested antimitochondrial antibodies in systemic sclerosis.

Cytometry-based blood immune cell markers associated with clinical outcomes in systemic sclerosis: protocol for a systematic review.

Mechanistic basis for the antifibrotic actions of cAMP-based therapies.

Management of pulmonary arterial hypertension in systemic sclerosis: from classical treatments to new horizons.

Assessing the structural validity of the SCL-Dep6 depression subscale using rasch analysis.

Systemic sclerosis-associated pulmonary arterial hypertension and pulmonary fibrosis: exploring biomarker discriminators with advanced omics in a Caucasian cohort.

An Under-Recognized Manifestation of Systemic Sclerosis: Macrovascular Peripheral Arterial Disease.

Prognostic biomarkers for idiopathic pulmonary fibrosis: findings from ISABELA clinical trials.

A potent inhibitor of PAI-1, MDI-2517, mitigates disease severity in a preclinical systemic sclerosis model.

Ustekinumab-associated morphoea: systematic review of the literature and a real-world case.

Facial Swelling in a Young Adult With Type 1 Diabetes: Morbihan Disease as a Scleroderma Mimic.

An autopsy-proven case of normotensive scleroderma renal crisis with refractory pleuroperitoneal effusion.

Oral and maxillofacial manifestations of systemic sclerosis.

Underrecognition of Fecal Incontinence in Systemic Sclerosis: Discrepancies Between the Rome IV Diagnostic Questionnaires and the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal 2.0 Questionnaire.

Administration of Hormone Replacement Therapy Containing Estrogen and Development of Autoimmune Associated Vocal Fold Lesions in Women.

Second to Fourth Digit Ratio (2D:4D) in Female Patients With Systemic Sclerosis: Evidence for Prenatal Androgen Exposure.

Assessing digital vasculopathy in systemic sclerosis.

Advancing drug development for systemic sclerosis by prioritizing findings from human genetic association studies.

Exploring the optimal follow-up for systemic sclerosis patients: study protocol for a Dutch multicenter randomized controlled trial.

Probabilistic Clustering Using Multivariate Growth Mixture Model in Clinical Settings-A Scleroderma Example.

Gastric disease in systemic sclerosis: Spectrum, challenges, and insights from a systematic literature review.

Quantifying the Prevalence of Disorders of Gut Brain Interaction in Systemic Sclerosis.

Evaluation of serial cardiovascular magnetic resonance monitoring and immunosuppressive therapy in predicting outcomes in systemic sclerosis.

Development of enzyme-linked immunosorbent assays for the detection of myositis-specific autoantibodies against signal recognition particle, nuclear matrix protein 2, and small ubiquitin-like modifier activating enzyme.

Analysis of the Dynamics of Clinical Parameters and Serum Angiogenic Factors in Systemic Sclerosis Patients Undergoing Tocilizumab Treatment.

Age and onset timing of Raynaud's phenomenon and first non-Raynaud symptom as prognostic factors in systemic sclerosis: a retrospective analysis from the Italian national multicenter Systemic Sclerosis Progression INvestiGation registry of the Italian Society for Rheumatology (SPRING-SIR).

Reactive oxygen species driven immune inflammation in systemic sclerosis: mechanisms and emerging therapeutics.

Delayed gastric emptying identifies a high-risk clinical subgroup in patients with systemic sclerosis.

Venous Abnormalities in Biopsy-confirmed Lipodermatosclerosis.

Multi-omics profiling of chronic immune-mediated skin diseases: SKINERGY protocol and strategic evaluation.

Gain of function NOTCH4 variants disrupt angiogenesis in systemic sclerosis.

Research on the mechanism of Carthamus tinctorius L. against skin fibrosis in systemic sclerosis based on serum pharmacochemistry, network pharmacology, and experimental validation.

The Spectrum of Uveitis and Retinal Vasculitis in Systemic Sclerosis: A Case Series.

Impact of Hydroxychloroquine on Mortality and Cardiovascular Outcomes in Systemic Sclerosis: A Retrospective Cohort Study.

Atypical Presentation of Morphoea in an Elderly Male: Diagnostic Challenges in the Absence of Autoantibodies and Malignancy.

Juvenile systemic sclerosis.

TPI1 and TPM4 are strong candidate RNA biomarkers for systemic sclerosis.

Spectroscopic and machine learning approaches for clinical subtyping in systemic sclerosis.

Comparing Novel and Legacy Health Assessment Questionnaire Scoring Methods: A Scleroderma Patient-centered Intervention Network Cohort Study.

Factor Analysis to Determine Subgroups of Gastrointestinal Symptoms in Systemic Sclerosis.

Gastrointestinal involvement in systemic sclerosis: A spotlight on small bowel involvement, complications and management.

Treatment of juvenile localized scleroderma with upadacitinib: A case series.

Th17-related genes PGAP1 and TMBIM1 serve as potential diagnostic and predictive biomarkers in systemic sclerosis: bioinformatic identification and murine model validation.

Risk stratifying systemic sclerosis-related pulmonary hypertension by left atrial strain.

Fc-enhanced anti-CCR6 antibody elicits robust therapeutic effects across multiple autoimmune diseases.

Renal Vascular Affection in Systemic Sclerosis Patients and Possible Correlation with Peripheral Vascular Involvement Assessed by Nailfold Capillaroscopy.

Evaluation of a screening algorithm to detect systemic sclerosis-related myopathy.

Methotrexate and Mycophenolate Mofetil and Clinical Response in Juvenile Localized Scleroderma.

Association of MMP9 and NOS3 Polymorphisms with Distinct Clinical Forms of Juvenile Scleroderma and Characteristics of Humoral Immunity.

Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: Current Therapeutic Strategies and Future Prospects.

Serum CCL18 May Reflect Multiorgan Involvement with Poor Outcome in Systemic Sclerosis.

JAK inhibitors for the treatment of juvenile localized scleroderma: a case report and literature review.

Close association of kinesiophobia with physical performance in patients with systemic sclerosis.

Prevalence and severity of complicated Raynaud's phenomenon in limited and diffuse systemic sclerosis: a multicenter study in Iraq.

Botulinum neurotoxin type A1 alleviates bleomycin-induced skin fibrosis by inhibiting phosphatidylinositol 3-kinase-protein kinase B (PI3K-Akt) pathway and associated cell cycle and proliferation.

Gastrointestinal histology of systemic sclerosis: A systematic review.

Patient partnership model in rare and complex rheumatological conditions: research and beyond in European Reference Network ReCONNET.

Strengthening rheumatology research through meaningful engagement of people with lived experience.

Development of a tool to map SSc pain sources, characteristics and management experiences: the SPIN Pain Assessment Tool.

Linear scleroderma 'en coup de sabre'.

Like an Osteophyte. . . or Worse? A Curious Case of Dysphagia in a Patient With Scleroderma.

Macrophages Are Critical Inducers of Bleomycin-Induced Fibrosis in a Systemic Scleroderma Model.

Surgical Management of Systemic Sclerosis: Review of Literature.

Forced vital capacity as a survival predictor in systemic sclerosis-associated pulmonary hypertension.

Esomeprazole inhibits proliferation of scleroderma fibroblasts via cell cycle regulation.

Beyond the breast: Mammographic manifestations of systemic disease.

Autoantibodies as Precision Tools in Connective Tissue Diseases: From Epiphenomenon to Endophenotype.

Differential Item Functioning on the Patient Health Questionnaire 8 by Disease Subtype, Language, Sex, and Age Among People With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study.

Systemic Sclerosis-Related Intestinal Pseudo-Obstruction Mimicking Mechanical Small Bowel Obstruction.

Contemporary 0.55 T MRI to visualize interstitial lung disease - An exploratory study.

The added value of cardiac MRI in paediatric rheumatologic disorders: a preliminary single-centre experience.

The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133).

Deficiency of inducible nitric oxide synthase alleviates dermal fibrosis and inflammation in scleroderma.

Associations with, and predictors of, progression in systemic sclerosis-related interstitial lung disease: a scoping literature review.

MASLD-Induced Hyperammonemia With Atypical, Restricted Diffusion Pattern Suggesting Mixed Metabolic and Hypoxic-Anoxic Injury.

Tofacitinib treatment in a girl with localized scleroderma of the head and face: a case-based review.

Skin Cancer Arising in Morphea: A Systematic Review.

A Case of Mandibular Osteomyelitis Occurring in a Patient With Parry-Romberg Syndrome.

Exploring the Association Between Autoimmune and Inflammatory Diseases and Uveitis.

Soluble CD13 in systemic sclerosis: clinical observations and transcriptomic insights from peripheral blood.

Temporal Dynamics of Pulmonary Fibrosis and Immune Dysregulation in a Collagen V-Driven Systemic Sclerosis Model.

Systemic Sclerosis-Associated ILD: Insights and Limitations of ScleroID.

A Case Report on a Challenge From Diagnosis to Treatment: Interstitial Lung Disease As the First Manifestation of Systemic Sclerosis Sine Scleroderma.

Heart Transplantation in Patients With Systemic Sclerosis.

Clinical Applications of Autologous Fat Grafting in Pathological Hand Conditions.

Disease Course and Risk of Relapse in Juvenile Localized Scleroderma: A Single-Center Retrospective Study.

Clinical predictors of mortality in critically ill systemic sclerosis patients: a 6-year retrospective cohort study.

CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial.

Transcriptomic analysis under the stress of insecticides and the functional role of three genes related to host finding behavior of Scleroderma sichuanensis.

Interstitial lung disease in systemic sclerosis-a retrospective cross-sectional study in Taiwan.

Mesenchymal stromal cells ameliorate systemic sclerosis-interstitial lung disease via PD-1/PD-L1 signalling axis.

Combination of Oral Hydroxychloroquine and Topical Pimecrolimus 1% for Linear Morphea in Breastfeeding: A Rare Case with Favorable Outcome.

Nailfold videocapillaroscopy in the assessment of juvenile connective tissue diseases.

Deficiency of NRF2 aggravates BLM-induced systemic sclerosis-associated fibrosis and inflammation in mice.

Expression and clinical significance of fatty acid metabolism-related genes in PBMCs of SSc patients.

Skin-derived myeloid precursors and joint-resident fibroblasts spread psoriatic disease from skin to joints.

Subclinical right ventricular dysfunction in juvenile systemic sclerosis: a cross-sectional echocardiographic study.

Gangrenous Digital Ischemia Unmasking HIV Infection in Untreated Systemic Sclerosis.

The Evolution in the Cutaneous and Gastrointestinal Pathology of Pediatric Kohlmeier-Degos Disease Under Combined Modality Therapy.

Parry-Romberg Syndrome Associated With En Coup De Sabre: A Clinical Case Report.

MYCOPHENOLATE MOFETIL TREATMENT REDUCES THE RISK OF TREATMENT ESCALATION DUE TO VASCULAR COMPLICATIONS IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS: EMULATION OF A TARGET TRIAL FROM ITALIAN RHEUMATOLOGY SOCIETY SPRING REGISTRY.

Chromosomal Instability and Telomere Attrition in Systemic Sclerosis: A Historical Perspective.

Autoimmune disorders as predictive factors for oral lichen planus and malignancy risk: real-world data analysis.

Hand function impairment in Systemic Sclerosis: determinants through investigations of clinical, radiographic and ultrasonographic features.

Pitfalls in the treatment of keloidal scleroderma.

Antineutrophil Cytoplasmic Antibody-Associated Vasculitides in Systemic Sclerosis: A Unique Clinical Overlap With Significant Implications for Treatment and Outcomes.

Single-Cell Profiling Reveals Divergent Mechanisms of Fibrosis in Localized Scleroderma and Systemic Sclerosis.

Effects of multimodal nutritional intervention on nutritional status and clinical outcomes in patients with systemic sclerosis: study protocol for a randomised controlled trial.

From the grey area of pre-systemic sclerosis to very early disease and irreversible tissue damage: the challenge of defining at-risk patients for future preventive trials in systemic sclerosis.

Atorvastatin alleviates the progression of fibrosis in experimental systemic sclerosis: Binding to macrophage CD14 to regulate TLR4/p65 or directly modulating fibroblast Smad3 signaling.

Systemic Sclerosis-Recent Advances in Diagnosis and Management.

Systemic Sclerosis-Associated Interstitial Lung Disease: Improved Understanding and Advances in Management.

Work participation and work disability in Belgian patients with systemic sclerosis.

Integration of natural language models in the diagnosis of systemic autoimmune diseases: validation of GPT-4 in a tertiary care center.

The altered T cell landscape in Systemic Sclerosis patients is characterized by dysfunctional type 1 immunity.

Underrepresentation of Black participants in systemic sclerosis clinical trials: the U.S.A. and southeast region.

The efficacy and safety of tocilizumab in juvenile localised scleroderma patients: a retrospective cohort study in Eastern China.

Radiographic Fibrosis Extent Identifies Immunomodulatory Treatment Response in Hypersensitivity Pneumonitis.

[Eosinophilic fascitis: A case report and literature review].

Phosphodiesterase-4 inhibition in localized scleroderma: A case series of topical roflumilast.

SgA1d, an acid lipase from venom of the ectoparasitoid Scleroderma guani involved in the regulation of host lipid metabolism.

Multimodal analyses of early, untreated systemic sclerosis skin identify a proinflammatory vascular niche of macrophage-fibroblast signaling.

Trigeminal neuropathy as the first symptom of mixed connective tissue disease: case report and literature review.

Serum profiling of uPA, PAI-1, and suPAR in systemic sclerosis: a preliminary study on analytical aspects and associations with microvascular and fibrotic manifestations.

Gut microbiome-metabolome dysregulation in systemic sclerosis: a multi-omics study.

Successful Treatment of Refractory Severe Localized Scleroderma With Anifrolumab.

Hidradenitis Suppurativa and Smoking, Obesity, Psoriasis, Inflammatory Bowel Disease, and Systemic Sclerosis: Results From A 2-Sample Mendelian Randomization Study.

Automated lung texture analysis for assessing interstitial lung disease in systemic sclerosis: Diagnostic accuracy in photon-counting-detector and conventional energy-integrating-detector CT.

[POEMS syndrome misdiagnosed as systemic sclerosis: A case report].

[Rheumatic disease spectrum and immunological profile of anti-PM/Scl antibodies in idiopathic inflammatory myopathies].